154 related articles for article (PubMed ID: 1087055)
1. On the characterization of acquired inhibitors to ristocetin induced platelet aggregation found in patients with von Willebrand's disease.
Egberg N; Blombäck M
Thromb Res; 1976 Nov; 9(5):527-31. PubMed ID: 1087055
[No Abstract] [Full Text] [Related]
2. [von Willebrand's disease with an increased ristocetin-induced platelet aggregation and a qualitative abnormality of the factor VIII protein (author's transl)].
Takahashi H; Oda E; Hattori A; Kobayashi I; Takahashi K; Sakuragawa N; Shibata A
Rinsho Ketsueki; 1980 Apr; 21(4):544-54. PubMed ID: 6774131
[No Abstract] [Full Text] [Related]
3. Dissociation between factor VIII (activity and antigen) and ristocetin-induced platelet aggregation in von Willebrand's disease.
Barbui T; Dini E
Acta Haematol; 1975; 53(1):44-8. PubMed ID: 807074
[TBL] [Abstract][Full Text] [Related]
4. [Ristocetin-induced platelet aggregation in von Willebrand's disease, thrombasthenia and essential athrombia with special reference to AHF-like antigen (author's transl)].
Ishiguro J; Kondo M; Ogata K; Takahashi T; Kamiya T
Rinsho Ketsueki; 1975 Jul; 16(7):716-24. PubMed ID: 1080812
[No Abstract] [Full Text] [Related]
5. Studies on the pathophysiology and treatment of von Willebrand's disease. IV. Mechanism of increased ristocetin-induced platelet aggregation in von Willebrand's disease.
Takahashi H
Thromb Res; 1980 Sep; 19(6):857-67. PubMed ID: 6781099
[No Abstract] [Full Text] [Related]
6. Proceedings: Two cases of von Willebrand's disease with specific inhibitors of ristocetin induced aggregation of normal platelets.
Blombäck M; Egberg N
Thromb Diath Haemorrh; 1975 Nov; 34(2):583. PubMed ID: 1081749
[No Abstract] [Full Text] [Related]
7. The von Willebrand syndrome.
Stableforth P; Hughes J; Wilson E; Dormandy KM
Br J Haematol; 1975 Apr; 29(4):605-16. PubMed ID: 1081404
[TBL] [Abstract][Full Text] [Related]
8. Platelet-bound ristocetin aggregation factor in normal subjects and patients with von Willebrand's disease.
Green D; Potter EV
J Lab Clin Med; 1976 Jun; 87(6):976-86. PubMed ID: 778313
[TBL] [Abstract][Full Text] [Related]
9. Relationship between ristocetin-induced platelet aggregation and factor VIII (activity and antigen) in v. Willebrand's disease.
Barbui T; Battista R; Dini E
Blut; 1974 Oct; 29(4):260-4. PubMed ID: 4547631
[No Abstract] [Full Text] [Related]
10. Diagnosis of von Willebrand's disease. A comparative study of diagnostic tests on nine families with von Willebrand's disease and its differential diagnosis from hemophilia and thrombocytopathy.
Lian EC; Deykin D
Am J Med; 1976 Mar; 60(3):344-56. PubMed ID: 1083143
[TBL] [Abstract][Full Text] [Related]
11. Evidence that the platelet retention factor is separate from the factor VIII-related antigen and factor VIII.
Rubin H; Alter AA; Walker MR; Stefanyshyn M; Scott L; Miotti AB
J Lab Clin Med; 1976 Jul; 88(1):14-21. PubMed ID: 180215
[TBL] [Abstract][Full Text] [Related]
12. Defective ristocetin-induced platelet aggregation in von Willebrand's disease and its correction by factor VIII.
Weiss HJ; Rogers J; Brand H
J Clin Invest; 1973 Nov; 52(11):2697-707. PubMed ID: 4201262
[TBL] [Abstract][Full Text] [Related]
13. The effect of ionophore on platelet aggregation in von Willebrand's disease and in congenital afibrinogenemia. A comparison with ristocetin.
Girolami A; Fabris F; Marco L; Peruffo R
Acta Haematol; 1976; 56(3):151-9. PubMed ID: 826070
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
Weiss HJ; Hoyer LW; Rickles FR; Varma A; Rogers J
J Clin Invest; 1973 Nov; 52(11):2708-16. PubMed ID: 4542944
[TBL] [Abstract][Full Text] [Related]
15. Factor VIII (Willebrand) antigen and ristocetin-Willebrand factor in pigs with von Willebrand's disease.
Fass DN; Brockway WJ; Owen CA; Bowie EJ
Thromb Res; 1976 Mar; 8(3):319-27. PubMed ID: 1083569
[No Abstract] [Full Text] [Related]
16. Development of an inhibitor specific to factor VIII: coagulant activity in a patient with platelet-type von Willebrand's disease.
Castella A; Miller JL; Neuberg RW; Gawryl MS; Hoyer LW
Am J Clin Pathol; 1983 Nov; 80(5):745-9. PubMed ID: 6416054
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity in von Willebrand's disease.
Ruggeri ZM; Zimmerman TS
Prog Clin Biol Res; 1981; 72():139-48. PubMed ID: 6801683
[No Abstract] [Full Text] [Related]
18. Evaluation of ristocetin-Willebrand factor assay and ristocetin-induced platelet aggregation.
Olson JD; Brockway WJ; Fass DN; Magnuson MA; Bowie EJ
Am J Clin Pathol; 1975 Feb; 63(2):210-8. PubMed ID: 1078748
[TBL] [Abstract][Full Text] [Related]
19. Ristocetin in the diagnosis of von willebrand's disease: a comparison of rate and percent of aggregation with levels of the plasma factor(s) necessary for ristocetin aggregation.
Dowling SV; Muntz RH; D'Souza S; Ekert H
Thromb Diath Haemorrh; 1975 Nov; 34(2):465-74. PubMed ID: 1081746
[TBL] [Abstract][Full Text] [Related]
20. An atypical von Willebrand's disease with hyperreactivity of platelet aggregation.
Niiya K; Kubonishi I; Taguchi H; Miyoshi I
Acta Haematol; 1984; 71(3):158-64. PubMed ID: 6424380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
